Research News - July 15, 2016

How well can you explain your science to a lay audience?

This fall during HUBweek, the Mass General Research Institute will host "The Art of Talking Science," an opportunity for researchers in the Boston area to give short presentations on their science and get feedback from a panel of communications experts, including Carl Zimmer, award-winning science writer for the New York Times, National Geographic and STAT.

If you are interested, please fill out our application form and add a link to a one-minute YouTube video introducing yourself and your science. This is going to be fun!

APPLICATION FORM

Click here to read the latest news from the NIH Office of Extramural Research.

1. Thursday, October 6, 8:00 am - 12:00 pm, O’Keeffe Auditorium & Bulfinch Tents
2.  

Celebrate MGH’s 14th Annual Clinical Research Day on Thursday, October 6 from 8:00am - 12:00pm. The day will kick-off with the keynote presentation The Clinical Applications of Gene Editing by Dr. Sandra Glucksmann, Chief Operating Officer, Editas Medicine

More details will be available in the next few weeks, including instructions on abstract submission and event schedule. Please mark your calendars and plan to attend. Questions may be directed to Jillian Tonelli.

MGH Clinical Research Day is brought to you by the Division of Clinical Research.

Monday, July 18 through Friday, July 29, MGH, Main Campus, 55 Fruit Street, O'Keefe Auditorium

Hans-Christian Reinecker, Course Director

The course is open to all fellows, students, house officers, research staff and faculty of all Harvard-affiliated institutions and institutions associated with the CSIBD. There is no charge for the course. However, all participants must register by sending an e-mail with the subject heading “Current Techniques in Molecular Genetics 2016” to Cristina Maria Crisman at ccrisman@partners.org. Please include the following in the text of the email: your name, your institution/department, your laboratory (PI’s name), your telephone number and your email address.

Sponsored by the Center for the Study of Inflammatory Bowel Disease, Massachusetts General
Hospital, and Beth Israel Deaconess Medical Center

For more information, please visit the website at
http://www.massgeneral.org/csibd/education/course.aspx

September 1 - October 20, 5:00pm - 6:30pm, Potts Conference Room

Sponsored by the MGH Division of Clinical Research, the Division of Infectious Diseases, and the Department of Psychiatry

Applications Due: August 15

Design and Conduct of Clinical Trials is an intensive fourteen-session course offered from early-September through late October. Physicians with a serious interest in clinical trials will be introduced to theoretical and practical issues facing clinical researchers.  Course participants will learn how to envision, plan, develop and execute effective clinical trials. Study content includes research designs, protocols, ethical patient recruitment, informed consent, regulations, and clinical trial management.
The course is ideally suited for clinical fellows starting their research years, junior faculty pursuing careers in clinical research, and physicians with an interest in becoming more actively involved in clinical research.  All participants are expected to use the course curriculum to develop and present a trial design at the final session of the course. 

To submit an application and/or view a course schedule, please go to: Design and Conduct of Clinical Trials. Contact Kelsey Gay with any questions.

The Executive Committee on Research (ECOR) is accepting applications for the August 1st deadline for the Deliberative Interim Support Funding.  August is the 3rd of three standing deadlines for these awards in Fiscal Year 2016.  The next deadline will be December 1, 2016. 

What are they?
Deliberative Interim Support Funding is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense).  Investigators must have applied for independent, long-term support (R01, R21, U01 and P01).  The Deliberative Interim Support process is open to:

1. Investigators whose grants were not scored or whose scores were not translated into a percentile ranking.
2. Investigators whose grants received scores >20th percentile.
3. Investigators who have already received Formulaic Bridge Funding or Deliberative Interim Support on their A0 grant application and are now requesting support for their A1 or A0 resubmission.  Investigators in this category must apply through the Deliberative Interim Support process for their A1 and A0 resubmission regardless of the score they received on their resubmitted grant.

When is the deadline?
Monday, August 1, 2016 - 5:00 PM

How do I learn more and apply?

Applications are now being accepted by the Executive Committee on Research (ECOR) for the MGH Claflin Distinguished Scholar Awards for Junior Faculty Women Investigators in Fundamental (Basic) & Clinical Research.

What are the Claflin Awards?
Although women scientists are recruited to Massachusetts General Hospital (MGH) programs, their advancement to senior faculty positions is still far less frequent than that of their male counterparts.  In 1993, The Women in Academic Medicine Committee, originally chaired by Mrs. R. Morton Claflin, Honorary Trustee, was established to facilitate the academic careers of women in science at MGH.  Recognizing that a significant obstacle to career advancement is the difficulty of maintaining research productivity during the child-rearing years, this Committee, with the sponsorship of the Executive Committee On Research (ECOR), established the Claflin Distinguished Scholar Awards.  It is intended that this funding will increase opportunities for women to advance to senior positions in academic medicine.

How much is each award?
These are two year awards for $50,000 per year in direct costs, plus 15% for indirect costs.

When is the deadline?
Tuesday, October 12, 2016 - 5:00 PM

How do I learn more and apply?
Click here to read more and apply online! For additional information, attend the Claflin Distinguished Scholar Awards Informational Panel Discussion.

Multiple program announcements for funding opportunities from the Department of Defense’s Congressionally Directed Medical Research Programs (CDMRP) have recently been released. To view a synopsis of all current program announcements, please click here or select a focus listed below.

·  Amyotrophic Lateral Sclerosis
·  Autism
·  Bone Marrow Failure
·  Breast Cancer
·  Defense Medical Research and Development Program
·  Duchenne Muscular Dystrophy
·  Gulf War Illness
·  Lung Cancer
·  Multiple Sclerosis
·  Neurofibromatosis
·  Orthotics and Prosthetics Outcomes
·  Ovarian Cancer
·  Peer Reviewed Cancer
·  Peer Reviewed Medical
·  Prostate Cancer
·  Psychological Health/Traumatic Brain Injury
·  Spinal Cord Injury
·  Tick-Borne Disease
·  Tuberous Sclerosis Complex

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

• Name of the Principal Investigator with appropriate contact information
• A descriptive title of the potential application
• Brief description of the project
• Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

• Clinical Research Education and Career Development (CRECD) Program (R25)
• Clinical and Translational Science Award U54
• Avon Breast Health Outreach Program (Avon BHOP) – NEW!
• Conference for Early Stage HIV/AIDS Vaccine Researchers (R13)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these funding opportunities.  Note that proposals are still routed through the standard InfoEd/Research Management process.

• Research Grant Program: Investigator Initiated Grants, A-T Children's Project
• In-Cycle Grant Opportunities:  Postdoctoral Research Fellowship Grant, A-T Children's Project
• In-Cycle Grant Opportunities:  Research Grant, A-T Children's Project
• Research Grant Program, Amyloidosis Foundation
• Open Call for Research Proposals, Angelman Syndrome Foundation, Inc. (ASF)
• Research Grants, Bruno and Ilse Frick Foundation for Research on ALS
• Grants, Prevent Cancer Foundation
• Fellowships, Prevent Cancer Foundation

Please click here for further details on these funding opportunities.

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm

Stepping Strong Innovator Awards
Application Deadline: July 18

Grand Challenges Canada - Stars in Reproductive, Maternal, Newborn and Child Health
Application Deadline:  July 19, 2016

Grand Challenges Canada - Saving Brains
Application Deadline:  July 29, 2016

MGH ECOR Formulaic Bridge Funding Support
Application Deadline: August 7; 7th day of each month

Medical Technology Enterprise Consortium Brain Machine Interface
Application Deadline: August 22

Linux & ERISOne Cluster Training Registration - 7/25 & 8/22

Clinical Research Fellows Orientation at MGH - July 25

Claflin Distinguished Scholar Awards Panel Discussion – August 9

Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals

Looking for something you saw in a previous Research News release? Check out our archive!